Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Details)

v3.19.2
Revenue Recognition (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Total revenues $ 2,606,398 $ 1,646,335 $ 5,078,915 $ 3,269,702
Functional Neurology [Member]        
Total revenues 1,690,122 1,159,527 3,294,767 2,338,862
Biologics And Drug Delivery [Member]        
Total revenues 244,949 111,792 529,859 292,258
Therapy [Member]        
Total revenues 17,830 17,830
Capital Equipment [Member]        
Total revenues 241,293 141,280 515,692 320,078
Product Revenues [Member]        
Total revenues 2,194,194 1,412,599 4,358,148 2,951,198
Capital Equipment and Other [Member]        
Total revenues 243,954 71,736 455,156 156,504
Biologics And Drug Delivery [Member]        
Total revenues 168,250 162,000 265,611 162,000
Service and Other Revenues [Member]        
Total revenues $ 412,204 $ 233,736 $ 720,767 $ 318,504